Categories: Technology

Constellation Software Inc. Announces Conference Call

 | Source: Constellation Software Inc.

TORONTO, Sept. 26, 2025 (GLOBE NEWSWIRE) — Constellation Software Inc. (TSX:CSU) (“Constellation” or “CSI”) announced today its President, Mark Miller, and its Chief Financial Officer, Jamal Baksh, will host a live shareholder question and answer audio webcast on October 1st, 2025 at 2:30 p.m. ET to discuss the transition of Constellation’s leadership from Mark Leonard to Mark Miller.

To access the call, please dial 1-877-879-1183 (North America toll free) or 1-412-902-6703 (International) and using conference ID 4557595.  A conference operator will create a queue and introduce each questioner.  You can also hear the call using the link https://edge.media-server.com/mmc/p/r8bx6qbj.  A replay of the call can be accessed using the link https://edge.media-server.com/mmc/p/r8bx6qbj for 12 months following the call.

About Constellation Software Inc.

Constellation’s common shares are listed on the Toronto Stock Exchange under the symbol “CSU”. Constellation Software acquires, manages and builds vertical market software businesses.

For further information:

Jamal Baksh
Chief Financial Officer
416-861-9677
info@csisoftware.com
www.csisoftware.com

GlobeNews Wire

Recent Posts

From Checks to Systems: Regula Recognized Across Key Layers of Identity Verification in 2026 Cybersecurity Excellence Awards

RESTON, Va., April 07, 2026 (GLOBE NEWSWIRE) -- Identity verification (IDV) is shifting from a…

3 hours ago

Naitiv Launches as the First AI-Native ServiceNow Consultancy

Founded by longtime ServiceNow leaders from Thirdera, the firm launches with acquisitions and a strategic…

3 hours ago

IP Strategy Highlights Arias Frontline K-Pop Release with RESCENE on Story

GIG HARBOR, Wash., April 07, 2026 (GLOBE NEWSWIRE) -- IP Strategy Holdings, Inc. (Nasdaq: IPST)…

3 hours ago

Emergent BioSolutions Launches New NARCAN Nasal Spray Carrying Case and Multipacks Alongside College Campus Outreach to Expand Opioid Overdose Preparedness

GAITHERSBURG, Md., April 07, 2026 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced…

3 hours ago

NextCure Receives Fast Track Designation for SIM0505 (CDH6 ADC) in Ovarian Cancer

April 07, 2026 08:05 ET  | Source: NextCure The U.S. Food and Drug Administration (FDA)…

3 hours ago

Valitor Announces Oral Presentation at the Upcoming Association for Research in Vision and Ophthalmology (ARVO) 2026 Annual Meeting

April 07, 2026 08:00 ET  | Source: Valitor, Inc. BERKELEY, Calif., April 07, 2026 (GLOBE NEWSWIRE)…

3 hours ago